Target intelligence / Profile preview

Ribonuclease A family member 4 (RNASE4)

Target
RNASE4
Molecular classification
Enzyme, Ribonuclease, Secreted protein, Pancreatic ribonuclease family
01

Overview

Ribonuclease 4 is a small, secreted enzyme (119 residues) of the ribonuclease A family, highly conserved across vertebrates[1][4]. It is characterized by strict specificity, cleaving RNA after uridine residues, and is found in human plasma and tissues such as pancreas, liver, saliva, and specifically in intestinal epithelial cells (notably goblet and Paneth cells)[1][3][5]. RNASE4 plays a major role in RNA metabolism, possesses antimicrobial activity against certain gut bacteria, induces angiogenesis, and protects neurons from degeneration[4][5]. It is co-expressed and shares promoter regions with angiogenin (RNASE5), another member of the ribonuclease A family, and is being investigated in the context of neurodegenerative diseases (ALS) and inflammatory bowel disease (IBD)[3][4][5]. Its structure is notable for having a shortened C-terminus that determines its substrate specificity[1][2]. Recombinant RNASE4 protein can stimulate neurogenesis and vascular formation in experimental models, and altered levels or genetic variants are associated with ALS risk and intestinal inflammation[4][5].

Other names
RNASE4RNase 4RNS4ribonuclease 4ribonuclease A B1epididymis secretory sperm binding proteinRAB1
02

Mechanism of action

Recombinant RNASE4 protein: angiogenesis stimulation, neuroprotection in ALS models via RNA cleavage and possible modulation of cellular differentiation. Antimicrobial activity: RNASE4 binds and kills specific gut bacteria such as Parasutterella, modulating the microbiome.

03

Biological functions

RNA cleavage (specific for uridine nucleotides)Antimicrobial defense in the gutAngiogenesis (formation of blood vessels)Neuroprotection (protecting neurons from degeneration)Regulation of gut microbiome
04

Disease associations

Amyotrophic lateral sclerosis (ALS)Frontotemporal dementiaInflammatory bowel disease (IBD)Potential role in infection and cancer
05

Safety considerations

No substantial clinical safety data exists; as a secreted host protein, risks relate to immune modulation and off-target effects in recombinant applications.Potential for unintended microbiota changes or excessive angiogenesis is a theoretical concern.
06

Biomarkers

RNASE4 protein levels in stool or intestinal tissue (for IBD diagnosis/monitoring)SNP rs3748338 in RNASE4 gene (risk modifier for ALS)

Beyond the preview

Go deeper on Ribonuclease A family member 4 (RNASE4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribonuclease A family member 4 (RNASE4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call